Document ID: chunk:federal_register_of_legislation:F2018L00855:reg:8:p2
Version: federal_register_of_legislation:F2018L00855
Segment Type: reg
Provision Reference: reg 8 (pt 2/2)
Character Range: 6049–6739

1 - Dictionary.
(12)      having a disorder from the specified list of disorders at the time of the clinical worsening of olecranon bursitis;
Note:  specified list of disorders is defined in the Schedule 1 - Dictionary.
(13)      having psoriasis, localised sclerosis, atopic dermatitis or another inflammatory skin disorder, where the skin disorder involves the skin of the extensor surface of the affected elbow, at the time of the clinical worsening of olecranon bursitis;
(14)      being treated with a tyrosine kinase inhibitor within the 30 days before the clinical worsening of olecranon bursitis;
(15)      inability to obtain appropriate clinical management for olecranon bursitis.